Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/03/1996 | US5580859 Biological injections into mamalian muscle of dna to express a therapeutic protein, polypeptide or peptide; vaccines; administering a dystrophin gene correcting muscular dystrophy |
12/03/1996 | US5580856 Formulation of a reconstituted protein, and method and kit for the production thereof |
12/03/1996 | US5580851 Inclusion complex of cyclodetrin and perfume |
12/03/1996 | US5580735 Mixing solvent, liquid silicone and functional amphiphilic compound, forming oil in water emulsion, covalently coupling ligand to amphiphilic compound, isolating microspherical particles |
12/03/1996 | US5580580 3-aminopyridine or 3,4-diaminopyridine; useful for multiple sclerosis and alzheimer's disease |
12/03/1996 | US5580579 Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
12/03/1996 | US5580578 Sustain released beads coated with a copolymers of acrylic and methacrylic esters having quaternary ammonium group; storage stability, waterproofing |
12/03/1996 | US5580576 Pharmaceutically/storage-stable nicorandil formulations |
12/03/1996 | US5580575 Therapeutic drug delivery systems |
12/03/1996 | US5580574 Including a benzodiazepine antagonist to overcome the sedative effects of the benzodiazepine active ingredient |
12/03/1996 | US5580573 Temperature activated controlled release |
12/03/1996 | US5580572 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
12/03/1996 | US5580570 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
12/03/1996 | US5580569 Article for tissue-specific delivery of therapeutic agents |
12/03/1996 | US5580546 Heating fatty body and polyhydric alcohol above melting point of wax, mixing with turbine operating at high rotation speed |
12/03/1996 | CA2016575C Method of aiding cessation of smoking |
12/03/1996 | CA1338771C Adhesion receptor for laminin and its use |
12/01/1996 | CA2177538A1 Apparatus, method and composition for preserving media in tip of solution dispenser |
11/28/1996 | WO1996037519A1 A polysaccharide hydrogel material, a process for its preparation and its use in medicine, surgery, cosmetics and for the preparation of health care products |
11/28/1996 | WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer |
11/28/1996 | WO1996037515A1 Process of high purity albumin production |
11/28/1996 | WO1996037285A1 Alkylpolyglycoside-based emulsifying composition and uses thereof |
11/28/1996 | WO1996037283A2 Method and device for delivering a substance |
11/28/1996 | WO1996037244A1 Medical device adhering to the skin |
11/28/1996 | WO1996037239A1 Peptide radiopharmaceutical applications |
11/28/1996 | WO1996037232A1 Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes |
11/28/1996 | WO1996037231A1 Skin permeation enhancer compositions using acyl lactylates |
11/28/1996 | WO1996037230A1 Immunostimulating-wound healing compositions and methods for preparing and using same |
11/28/1996 | WO1996037229A1 Antihistamine-wound healing compositions and methods for preparing and using same |
11/28/1996 | WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same |
11/28/1996 | WO1996037227A1 Dermatological-wound healing compositions and methods for preparing and using same |
11/28/1996 | WO1996037215A1 Oral insulin delivery |
11/28/1996 | WO1996037202A1 Dosage form comprising oxybutynin |
11/28/1996 | WO1996037198A1 Use by inhalation of antidepressants for the treatment of asthma |
11/28/1996 | WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same |
11/28/1996 | WO1996037195A1 Novel pharmaceutical pellet formulation |
11/28/1996 | WO1996037194A1 Delivery vehicles comprising stable lipid/nucleic acid complexes |
11/28/1996 | WO1996037193A1 Topically applicable agents for treating and preventing alopecia |
11/28/1996 | WO1996037192A1 Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids |
11/28/1996 | WO1996037191A1 Antibacterial compositions |
11/28/1996 | WO1996037190A1 Stable, concentrated, locally-tolerated erythromycylamine solutions |
11/28/1996 | WO1996037189A1 Osmotic device with high drug loading and delayed activation of drug delivery |
11/28/1996 | WO1996037188A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament |
11/28/1996 | WO1996037180A1 Stabilized pseudo-emulsions and their preparation process |
11/28/1996 | WO1996037118A1 Chronological food bar |
11/28/1996 | WO1996033695A3 Gel with increased oxygen content |
11/28/1996 | WO1996032931A3 Composite with sodium starch glycolate as a support material and products thereof |
11/28/1996 | WO1996030010A3 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
11/28/1996 | DE19620534A1 Verfahren zur Kontrolle der exothermen Reaktion einer exothermen Verbindung, der exothermen Verbindung, einer exothermen Vorrichtung und einer Applikationskompresse A method of controlling the exothermic reaction of an exothermic compound, the exothermic compound, an exothermic device and a Applikationskompresse |
11/28/1996 | DE19519273A1 Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie Topically applicable agent for the treatment and prophylaxis of alopecia |
11/28/1996 | DE19518917A1 Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen Stable, concentrated locally acceptable solutions erythromycylamine |
11/28/1996 | DE19518721A1 Drum coater for nuclei, esp. pharmaceutical tablets and capsules |
11/28/1996 | DE19517145C1 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron Transdermal therapeutic system (TTS) for the administration of testosterone |
11/28/1996 | CA2510391A1 Dosage form comprising oxybutynin |
11/28/1996 | CA2222061A1 Agents that can be administered topically for treatment and prophylaxis of alopecia |
11/28/1996 | CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same |
11/28/1996 | CA2221206A1 Method of delivering substance into a material mass |
11/28/1996 | CA2220950A1 Delivery vehicles comprising stable lipid/nucleic acid complexes |
11/28/1996 | CA2220926A1 Chronological food bar |
11/28/1996 | CA2219824A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament |
11/28/1996 | CA2219492A1 Peptide radiopharmaceutical applications |
11/28/1996 | CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer |
11/28/1996 | CA2218539A1 Immunostimulating-wound healing compositions and methods for preparing and using same |
11/28/1996 | CA2217029A1 Skin permeation enhancer compositions using acyl lactylates |
11/28/1996 | CA2191597A1 Antibacterial compositions |
11/27/1996 | EP0743984A1 Nucleic acid-containing composition, its preparation and use |
11/27/1996 | EP0743860A1 Preparation of hollow microcapsules |
11/27/1996 | EP0743854A1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production |
11/27/1996 | EP0743851A1 Lipophilic carrier preparations |
11/27/1996 | EP0743850A1 Rapidly dissolving oral dosage form |
11/27/1996 | EP0743842A1 Drug-containing adhesive composite transdermal delivery device |
11/27/1996 | EP0662835B1 New pharmaceutical formulations of spiramycine |
11/27/1996 | EP0625900B1 Compositions and processes for the sustained release of drugs |
11/27/1996 | EP0568651A4 Biodegradable polymer blends for drug delivery |
11/27/1996 | EP0505478B1 A treatment system for wounds and other disorders |
11/27/1996 | EP0494972B1 Effervescent dosage form and method of administering same |
11/27/1996 | CN2240981Y Anti-colitis capsule |
11/27/1996 | CN1136826A Recombinant P53 adenovirus method and compositions |
11/27/1996 | CN1136779A Long-acting injection suspensions and process for their preparation |
11/27/1996 | CN1136776A Oral formulations of antifungal |
11/27/1996 | CN1136774A Pharmaceutical emulsion |
11/27/1996 | CN1136773A Transdermal delivery device |
11/27/1996 | CN1136555A Nerve amide compound, its preparing method and its use |
11/27/1996 | CN1136453A Antidiarrheal and its preparing method |
11/27/1996 | CN1136451A Piles curing liquid |
11/27/1996 | CN1136446A Soft capsule of gynostemma pentaphylla total glycoside and its preparing technology |
11/27/1996 | CN1136436A Tablet for clearing head for cerebrorascular disease |
11/27/1996 | CN1033390C Preparation of beta-form thiamine hydrochloride crystals |
11/27/1996 | CN1033365C Preparing method for lipides composition containing scutellaria compound |
11/26/1996 | US5578709 Polyvinylpyrrolidone, polyoxyethylene glycol |
11/26/1996 | US5578600 Vitamins b1 and b12, sugar alcohol |
11/26/1996 | US5578588 Nasal administration of a precursor |
11/26/1996 | US5578586 Aqueous film coating for wetting eye surfaces |
11/26/1996 | US5578583 Microemulsions used as vehicles for carrying chemotherapeutic agents to neoplastic cells |
11/26/1996 | US5578580 Sustained release microcapsules containing erythromycin thiocyanate; masked taste and smell |
11/26/1996 | US5578578 Ophthalmic solutions |
11/26/1996 | US5578567 Nasal pharmaceutical composition |
11/26/1996 | US5578565 Reconstituted platelet membrane vesicles |
11/26/1996 | US5578475 Composition and methods for transfecting eukaryotic cells |
11/26/1996 | US5578469 Process for preparing neotrehalose, and its uses |